Menu
Search
|

Menu

Close
X

Novartis AG NOVN.S (Virt-X Level 1)

92.52 CHF
-0.52 (-0.56%)
As of 12:30 PM EDT
Previous Close 93.04
Open 92.50
Volume 3,643,614
3m Avg Volume 5,134,413
Today’s High 93.06
Today’s Low 92.32
52 Week High 93.96
52 Week Low 71.84
Shares Outstanding (mil) 2,550.62
Market Capitalization (mil) 237,692.91
Forward P/E 17.44
Dividend (Yield %) 2.85 ( 3.01 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.25 Mean rating from 28 analysts

KEY STATS

Revenue (mm, USD)
FY18
53,166
FY17
50,135
FY16
49,386
EPS (USD)
FY18
5.379
FY17
3.226
FY16
2.798
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
17.44
58.10
Price to Sales (TTM)
vs sector
4.50
8.84
Price to Book (MRQ)
vs sector
2.76
4.60
Price to Cash Flow (TTM)
vs sector
12.27
40.07
Total Debt to Equity (MRQ)
vs sector
40.89
17.66
LT Debt to Equity (MRQ)
vs sector
28.58
13.97
Return on Investment (TTM)
vs sector
11.19
12.12
Return on Equity (TTM)
vs sector
16.51
13.24

EXECUTIVE LEADERSHIP

Joerg Reinhardt
Independent Non-Executive Chairman of the Board, Since 2013
Salary: --
Bonus: --
Alex Krauer
Honorary Chairman of the Board, Since
Salary: --
Bonus: --
Daniel Vasella
Honorary Chairman of the Board, Since
Salary: CHF707,283.00
Bonus: CHF697,148.00
Vasant Narasimhan
Chief Executive Officer, Member of the Executive Committee, Since 2018
Salary: --
Bonus: CHF1,594,800.00
Enrico Vanni
Independent Non-Executive Vice Chairman of the Board, Since 2013
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

Lichtstrasse 35
BASEL     4056

Phone: +4161.3241111

Novartis AG is a holding company, which provides healthcare solutions. The Company is engaged in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. The Company's segments include Innovative Medicines, Sandoz, Alcon and Corporate activities. Innovative Medicines researches, develops, manufactures, distributes and sells patented prescription medicines to develop health outcomes for patients and healthcare providers. Sandoz develops, manufactures, distributes and sells prescription medicines, as well as pharmaceutical active substances that are not protected by valid and enforceable third-party patents. Alcon researches, develops, manufactures, distributes and sells eye care products. Alcon is a provider of eye care with product offerings in eye care devices and vision care. The Company's range of products includes pharmaceuticals and oncology medicines, generic and biosimilar medicines, and eye care devices.

SPONSORED STORIES